Skip to main content
Erschienen in: BMC Oral Health 1/2024

Open Access 01.12.2024 | Research

Evaluation and comparison of the effects of a new paste containing 8% L-Arginine and CaCO3 plus KNO3 on dentinal tubules occlusion and dental sensitivity: a randomized, triple blinded clinical trial study

verfasst von: Hamideh Sadat Mohammadipour, Hossein Bagheri, Saber Babazadeh, Mehrzad Khorshid, Zahra Shooshtari, Arsalan Shahri

Erschienen in: BMC Oral Health | Ausgabe 1/2024

Abstract

Background

Dentin hypersensitivity, often occurring after dental treatments or from erosive lesions, is a prevalent patient complaint. This study introduces a paste combining 8% L-arginine, calcium carbonate, and potassium nitrate to evaluate its impact on dentinal tubules occlusion, dentin permeability, and tooth sensitivity.

Methods

Dentin surfaces from 24 third molars (thickness: 2 mm) were divided into two groups of 12. One received the experimental paste, while the other received a placebo without desensitizer. Permeability and sealing ability were assessed through scanning electron microscopy (SEM) and dentin permeability measurement. The pastes’ effects on hypersensitivity were then examined in a triple-blind, randomized parallel-armed clinical trial with 16 eligible patients. Sensitivity to cold, touch, and spontaneous stimuli was recorded using the VAS scale at various intervals post-treatment. Statistical analysis was conducted using Shapiro-Wilk, Mann-Whitney U, Friedman, and Wilcoxon tests (α = 0.05).

Results

The permeability test demonstrated a significant reduction in dentin permeability in the experimental group (P = 0.002) compared to the control (P = 0.178). SEM images revealed most dentinal tubules in the intervention samples to be occluded. Clinically, both groups showed a significant decrease in the three types of evaluated sensitivity throughout the study. However, no significant difference in sensitivities between the two groups was observed, with the exception of cold sensitivity at three months post-treatment (P = 0.054).

Conclusion

The innovative desensitizing paste featuring 8% L-arginine, calcium carbonate, and potassium nitrate effectively occluded dentinal tubules and reduced dentin permeability. It mitigated immediate and prolonged dentin hypersensitivity to various stimuli, supporting its potential role in managing dentin hypersensitivity.

Trial registration

http://​irct.​ir: IRCT20220829055822N1, September 9th, 2022.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Tooth sensitivity is one of the adults’ most common dental problems, characterized by short, sharp, and transient pain. In a meta-analysis study, the prevalence of tooth sensitivity ranged from 2.8 to 74% [1]. There is still no precise rationale for tooth sensitivity [2, 3]. Among all mechanisms suggested by now, Brannstrom proposed the theory of hydrodynamics (Fluid Movement/Hydrodynamic) in 1964. The aforementioned theory is the most acceptable theory based on the dynamic flow of dentinal fluid [4]. Usually, when dentin tubules are exposed to the external environment, different stimuli can make the fluid in dentin tubules to move, which leads to nerve fiber stimulation and pain [5]. The cause of tubule exposure is multi-factorial. Generally, the gradual wearing of enamel or gingival recession (which causes dentin or root surface cementum exposure, respectively) is the most common cause [6]. Usually, creating an outward flow caused by stimuli such as cold, dryness, and hyperosmotic solutions makes the tooth more sensitive than a flow toward the pulp (for example, by heat) [3]. The most common stimulus in dentin hypersensitivity (DH) is cold air flow, such as breathing in cold winter air or applying a dental unit air syringe [7].
Several active substances have been introduced for the treatment of DH. CPP-ACP (derived from cow’s milk protein, casein, calcium, and phosphate) [8], TCP (tricalcium phosphate, a calcium phosphate system which is stable in aqueous environments [9], Remin Pro (containing hydroxyapatite, fluoride, and xylitol) [10], Pro-Argin (containing arginine/calcium carbonate) [11], and NovaMin (containing calcium sodium phosphosilicate (CSPS)) [12] have shown positive results. Different commercial products have been offered for each of the aforementioned mechanisms, some of which contain one or more active ingredients that use only one anti-sensitive mechanism for treatment. Nevertheless, some of these substances treat sensitivity using two or more active agents, employing the effects of both mechanisms (physical blockage and nerve stimulation).
Arginine is an essential amino acid with an alkaline pH, and its dentin-desensitizing effect in combination with calcium carbonate (as a rich source of calcium ions) has been proven in previous studies, both in-vitro and in the clinic [11, 1319]. Arginine and calcium ions, which are positively charged at physiological pH (alkaline by bicarbonate buffer), bind to the negatively charged dentin surface and create a calcium-rich layer [11].
By increasing the potassium concentration in nerve endings and preventing the generation of action potentials in interdental nerves, potassium salts have become the most popular desensitizer of dental nerves, whose dentin desensitizing effect has been proved in previous studies [2024]. By causing depolarization, potassium salts prevent repolarization and transmission of pain messages through nerves. Potassium nitrate (5%), potassium chloride (3.75%), and potassium citrate (5.5%), all of which contain 2% potassium ions, are used as active ingredients [25]. Professional pastes, toothpastes, and gels containing potassium nitrate are specifically used to reduce the incidence of tooth sensitivity during the dental bleaching period. For this purpose, patient should start the treatment two weeks before the beginning of the bleaching period and continue treatment during the bleaching process.
To the best of the authors’ knowledge, no studies have evaluated the potential of the combination of Pro-Argin and KNO3 agents as a double-action anti-sensitive treatment. Few studies evaluating the combination of two mechanisms together have been published. Even those that utilized both mechanisms of action did not implement the Pro-Argin agent as an occluding mechanism [26].
Pain, as one of the permanent and apparent characteristics of dentin hypersensitivity, affects quality of life [27]. Recently, the Dentine Hypersensitivity Experience Questionnaire (DHEQ) was designed to evaluate the impact of DH on the quality of life. To prevent dentinal sensitivity recurrence, identifying etiological factors such as improper brushing technique, poor oral hygiene, premature occlusion contacts, gingival recession, and exogenous/endogenous acids is crucial [28]. However, due to the difficulty, impossibility and time-consuming nature of removing all the primary causes, the most common action in the clinic is the use of anti-sensitive agents in-office and recommend to keep using at home. This work aimed to evaluate the effect of a new combination paste containing 8% L-Arginine and CaCO3 plus KNO3 in treating DH in non-carious lesions. The null hypotheses tested in this study are as follows:
  • There would be no difference between the two pastes with and without the desensitizing agents (8% L-Arginine and CaCO3 plus KNO3) in terms of dentinal tubule permeability.
  • There would be no difference in reducing tooth sensitivity effectiveness between the two pastes.

Methods

New paste composition and production steps

The following steps were taken to synthesize a final volume of 20 ccs of 5% potassium nitrate paste and 8% arginine-calcium carbonate using the materials listed in Table 1. First, 1.6 g (gr) of arginine (Merck, Darmstadt, Germany) was added to a mixture containing 0.24 g of calcium carbonate (Dr. Mojallali Co., Iran) dissolved in 16 cc of distilled water (Kimia Co., Iran) and mixed to become homogeneous. The solution was mixed with a magnetic stirrer. Then 1 g of potassium nitrate (Merck, Darmstadt, Germany) and 4 cc of glycerin (Merck, Darmstadt, Germany) were added to the solution. Finally, to increase its wettability and reach the desired consistency, 0.3 g of CMC (Merck, Darmstadt, Germany) and 1.5 g of silica (Tetrachem Co., Iran) were slowly added to dissolve.
Table 1
The materials used in the present study to formulate the experimental anti-sensitive paste
Materials
Lot number
Role
Manufacturers
Arginine
K50676042
Anti-sensitive agent
Merck, Darmstadt, Germany
Calcium Carbonate
0127112112
Anti-sensitive agent
Dr. Mojallali Co., Iran
Potassium Nitrate
3,000,250
Anti-sensitive agent
Merck, Darmstadt, Germany
Distilled water
NA
Solvent
Kimia Co., Iran
Glycerol
K45347592
Humectant, Thickening agent
Merck, Darmstadt, Germany
Sodium Bicarbonate
K40235123
Buffer
Merck, Darmstadt, Germany
Carboxy Methyl Cellulose (CMC)
6,143,922
Thickening agent
Merck, Darmstadt, Germany
Silica
381,276
Thickening agent, Anti-sensitive agent
Tetra chem Co, Iran
NA, not applicable
The pH evaluation was accomplished; then, sodium bicarbonate (Merck, Darmstadt, Germany) solution was used to adjust the pH if needed. A digital pH meter (WTW Multiparameter benchtop meter inoLab® Multi 9620 IDS) was used. The final paste with 8–9 pH was packed in a tube and stored in a refrigerator for 24 h (Fig. 1).

Study design

This triple-blinded, randomized, parallel-arm designed clinical trial with 1:1 allocation ratio, accompanied by a preclinical stage (in-vitro), was conducted at the Department of Cosmetic and Restorative Dentistry and Dental Materials Lab of Mashhad University of Medical Sciences, Iran, from June to August 2022. The study protocol was approved by the local ethical committee of the university (protocol number IR.MUMS.DENTISTRY.REC.1401.002) on April 6, 2022, in accordance with the World Medical Association Declaration of Helsinki. This study also followed the recommendations of the Consolidated Standards of Reporting Trials (CONSORT) statement [29]. The clinical trial was registered in the Iranian Registry of Clinical Trials (http://​irct.​ir) under the identification number IRCT20220829055822N1 on 09/09/2022. Before participation, the purpose of the study, risks, side effects, and benefits were thoroughly explained to the patients, and written informed consent was obtained from those willing to participate in the study.

In-vitro phase (Assessment of dentine permeability)

Twenty-four human wisdom teeth with intact facial surfaces were selected for the study, with the sole exclusion criterion being the presence of any fractures. The teeth were disinfected in 0.5 wt% Chloramine-T for 72 h at 37 °C in an incubator, and any tissue remnants around the teeth were carefully removed. Subsequently, the teeth were vertically mounted (with the occlusal surface facing upward) in self-cured acrylic resin blocks (3 cm × 3 cm) from Marlic Co., Tehran, Iran. The buccal surface was meticulously trimmed using a trimmer (MESTRA RH-3000, Iran) until a smooth inner dentin surface was achieved. The exposed surface was further polished with sequential abrasive papers (800, 1000, and 1200-grit, Starcke; Germany) suspended in water to enhance the enamel’s smoothness (Fig. 2, (a)). All molars were carefully sectioned at the CEJ using the trimmer machine to provide access to the pulp chamber. After removing the pulp without touching the dentin walls, the pulp chamber was thoroughly rinsed with deionized water (Fig. 2, (b)). Subsequently, one side of the laboratory tubing was connected to the pulp chamber’s opening using cyanoacrylate glue, while the other side was connected to a pulp pressure simulator. If necessary, the opening at the bottom of the pulp chamber was widened using a turbine fissure bur (Diaswiss Co., Swiss) with water spray. To reveal the buccal dentin tubules, the remaining thin smear layer on the buccal dentin was etched by immersing it in a 0.5 M Ethylene Diamine Tetraacetic Acid (EDTA) solution (Merck Co., Inc, USA) for 2 min in an ultrasonic machine (Lyman Digital Ultrasonic Cleaner 2500 ml). Afterward, each sample was rinsed with deionized water for 30 s (Fig. 2, (c)).
All the samples were numbered and divided into two groups (12 samples each) according to the proposed later treatment. At this stage, one sample from each group was used as a control for SEM, to ensure the smear layer’s removal and the tubules’ complete opening after immersion in the EDTA solution (Fig. 3, (A)). Other samples were kept in artificial saliva until the initial permeability measurement. The artificial saliva was formulated as previously described [30].
Group 1
New toothpaste containing Arginine and CaCO3.
Group 2
Base paste without any active agent (control group).

Baseline data measurement

After group division, permeability measurements were performed. Primary permeability was assessed (Fluid Filtration Machine, Iran) for each sample with open dentin tubules using a water pressure of 70 cm (6.68 kPa). A ceiling suspended deionized water syringe supplied a hydrostatic pressure of 1 psi (70 cm H2O) through a micropipette to the pulpal chamber of the dentine samples via laboratory tubing. Before recording the permeability, the mixture was left for 2 min so that the liquid infiltrated into all dentin tubules. After 8 min, the amount of microleakage of water was read from the device to determine the primary permeability. The primary permeability of each tooth was compared with the permeability of the same tooth after the intervention. The baseline fluid flow (before the intervention) showed 100% permeability, and the permeability after the intervention was recorded as a percentage of the maximum amount.

Application procedure

Twenty-four dentin samples prepared in the previous stage were randomly divided into two groups. In the intervention group, the formulated paste containing the active substance was used to reduce permeability, and in the control group, the base paste without the active substance was used.
The paste was used each day for 10 min for a week. At the same time while using the pastes on samples under the simulated pressure of the pulp, natural saliva was used on the surface of the buccal dentin to fully simulate the enzymes of the oral environment (including Arginine Deiminase). Natural saliva was prepared daily and before the application procedure. After 10 min of applying the paste, the dentin surfaces were washed for 30 s with running water, without pressure and any touch contact of surface, to remove the paste from the dentin surface. Each sample was transferred to a separate artificial saliva vial for storage until the next day in order to avoid dehydration. Artificial saliva was prepared based on the formulation of Zhou et al. [31], as previously described. The vials were kept in an incubator at 37 °C throughout the experiment. When each vial was removed from the incubator, it was allowed to equilibrate to ambient temperature for 30 min before measuring the liquid filtration.

Final measurement

After 7 days, similar to the basic permeability measurement process, first we gave 2 min for the device to fill the tubules with water and equalize the pressure. Then, within 8 min, the microleakage was read to achieve final permeability.

SEM phase (Assessment of tubule occlusion)

In addition to the two control samples that were previously scanned to ensure the opening of the tubules, two other samples from each group were randomly selected and prepared for observation by SEM. We employed SEM exclusively to enrich our findings qualitatively, thus, according to previous studies [32, 33], this sample size from each group sufficed. For this purpose, the samples were kept in 10% formalin solution for 48 h to stabilize. These samples were dehydrated in increasing concentrations of alcohol solutions containing 70, 80, 90, 95, and 100% alcohol, for 10 min each. After the dehydration process, the samples were first air-dried and then kept overnight in closed containers containing calcium sulfate (Drierite, W.A. Hammond, Xenia, OH, USA). The dried samples were mounted on microscope bases (SEM stubs). The mounted samples were observed using SEM (XL30, FEI, Hillsboro, OR, USA) at 10–20 kV, and photographs were taken of multiple areas at 5000x magnification. Finally, the open or closed tubules were checked under descriptive analysis (Fig. 3).

Clinical phase (Assessment of dentine sensitivity in patients)

Sample size calculation

20 patients were included in the clinical part of this study, which was designed as a triple-blind clinical trial, according to the following criteria. According to the Split-Mouth method used in this study, each individual was both the intervention and control group simultaneously, makes each group size 20 and also reducing confounding factors.

Inclusion and exclusion criteria

Comprehensive dental examination was performed on all patients to determine their eligibility. The inclusion criteria are stated below:
  • Patients with dentin hypersensitivity due to gingival recession and limited cervical lesions who do not need extensive treatment such as restoration.
  • Patients aged 18 to 50 years.
  • Patients in good general and oral health conditions.
  • Patients not having a history of illness or long-term drug use.
  • Patients not having a history of desensitizing treatment in the last six months.

Exclusion criteria

  • The patients’ unwillingness to continue cooperation or who do not appear in visit sessions.
  • Patients who use orthodontic appliances.

Randomization

Initially, ten men and ten women were selected to eliminate the effect of gender and the difference in pain tolerance. The randomization procedure was performed by www.​random.​org. An individual who was unaware of the research protocol created opaque consecutively numbered envelopes with information about the groups inside. The envelopes were opened by patients just before the treatment to select the right and left quadrants as the control or intervention group. We assessed the most sensitive tooth in each quadrant. Each participant’s measurements were done only in one jaw, either upper or the lower one.

Blinding

This study was designed as a triple-blind, in which the patient, evaluator, and statistician were blinded to the type of treatment. Both pastes were made with the same consistency, color, taste, and odor in identical syringes labeled A and B. A different researcher (not involved in the assessments) was responsible for the randomization process, applying the pastes based on codes A and B.

Study intervention

A retractor was used to retract the lips. In the control quadrant, paste without an anti-sensitive agent was used, and in the test quadrant, paste containing the anti-sensitive agent was used on the teeth. The anti-sensitive treatment process was performed in 2 visits on two consecutive days, each lasting for 30 min, to increase efficacy. While using the paste in the mouth, suction was used to control saliva flow, but the teeth were not thoroughly dried, so that some small amount of saliva could provide natural enzymes. Since the purpose of producing this material was to be easily used by patients at home, and not to require any specialized equipment, the paste was applied by finger and rubbed for 60 s and three times during the 30 min treatment session.
In order to standardize the oral hygiene conditions of the patients during the study, each was given a daily toothpaste containing 1450 ppm of fluoride (Pooneh, Iran) to use at least twice a day. This way, the disruptive effect of other dental desensitizers during the study was minimized. Patients were also asked not to use mineralizing substances, mouthwashes, or other toothpastes duringthe treatment period.

Sensitivity evaluation

The Visual Analogue Scale (VAS) was used to evaluate dental sensitivity. Before the start of the treatment (T0) and immediately after the end of the treatment on the second day (T1), the level of sensitivity to stimulating stimuli and spontaneous sensitivity to different stimuli were recorded. The assessment of sensitivity to cold stimulus was done by directing a 3-second application of compressed air from a triple air dental syringe perpendicular to the cervical third of teeth from an approximate 1-cm distance. During the assessment of cold sensitivity, adjacent teeth were covered with cotton rolls so that they would not be affected. Central teeth were not evaluated due to the possibility of interfering with the perception of sensitivity by the patient. However, non-evaluated teeth also received anti-sensitive treatment to take ethical considerations into account.
24 h (T2), one week (T3), one month (T4), and three months (T5) after the treatment, the patients were asked to visit return, and the level of dental sensitivity was reevaluated. At the end of the evaluations, if requested by the patient, treatment was also performed for other sensitive teeth.

Statistical analysis

The in-vitro data was normally distributed while the clinical data were not, as determined by the Kolmogorov Smirnov test. Statistical analyses were conducted using SPSS version 26.0 software, with a 5% significance level. For Phase 1 and 2, dentin permeability was measured as a percentage of base permeability, considered 100%. Repeated measures ANOVA and the paired T-test were used to compare study groups and fluid infiltration results, respectively. SEM images were qualitatively compared. Sample size was set to 12 per group, based on Zhou et al.’s study and assuming 80% test power and a 5% type I error rate. For Phase 3, due to the non-normal distribution of data, sensitivity was classified as painless (score 0), weak (scores 1–3), moderate (scores 4–6), and high sensitivity (scores 7–10). Non-parametric tests were used to compare these categories. Changes over time and from baseline were assessed using the Mann-Whitney, Friedman, and Wilcoxon Signed Ranks Tests, respectively. The data were visualized with tables and graphs. Twenty participants were selected for the clinical study, allowing for dropouts while ensuring statistical power.

Results

Phases 1 and 2

The primary and final dentin permeability were calculated, and by dividing these numbers, the final permeability was obtained in microliters per minute. The before and after permeability results in each group were compared with Paired T-test and final permeabilities are reported as a percentage of initial permeability in Table 2. As shown, the decrease in permeability was significant only in the intervention group (p = 0.002) and not in the control group (p = 0.178).
Table 2
Comparison of permeability reduction in intervention and control groups
Group
Final permeability (%)
Mean difference ± SD
P value
(paired t-test)
Intervention
58%
0.86 ± 0.70
0.002*
Control
75%
0.59 ± 1.35
0.178
*: Significant at P ≤ 0.05
As shown in Fig. 3, in part A, the openings of the dentin tubules are completely open and the smear layer and smear plugs have been removed. In part B, the base paste without anti-sensitive active ingredient is used, it covers the surface and closes the opening of some dentin tubules, but open dentin tubules are still visible. In part C, where the paste with the active ingredient Arginine/Calcium Carbonate along with Potassium Nitrate is used, the surface coating is thicker and more uniform. Furthermore, it almost closed all the opening of the dentinal tubules in many areas. It indicates the sealing properties of the intervention paste.

Phase 3

Participant characteristics

The clinical trial started with 20 patients, including ten men and ten women. The participants’ mean age was 25.75 ± 4.25 years (range between 21 and 44 years). Unfortunately, three patients have not participated in the final evaluation. They were excluded (one due to a diagnosis of proximal caries, one due to performing another dental procedure during the follow-ups, and one due to not cooperating with the follow-ups). Therefore, data from 17 subjects were gathered and analyzed after three months (Fig. 4).

Within-treatment sensitivity comparisons through time

To compare the sensitivity values, nonparametric analyses were used due to the lack of normality in the data (P < 0.050).
The Friedman analysis of the VAS score results indicated that the intervention paste significantly decreased cold and tactile sensitivity immediately after the treatment (P = 0.001), while the control paste significantly decreased the cold sensitivity only. The Wilcoxon rank test indicated that from T1 onwards, the difference between follow-ups was insignificant in either group. Also, no significant difference was observed in terms of spontaneous sensitivity in either group (Table 3). The data are visualized clearly in Fig. 5.
Table 3
Within-treatment sensitivity comparisons through time
Group
Time Point
Cold sensitivity
Tactile sensitivity
Spontaneous sensitivity
Mean Rank
Friedman Test
Mean Rank
Friedman Test
Mean Rank
Friedman Test
Control
T0
5.21 a*
χ2 = 32.40
P < 0.001
4.09
χ2 = 9.47
p = 0.092
4.09
χ2 = 5.000
p = 0.416
T1
2.91 b
3.59
3.59
T2
3.21 b
3.47
3.47
T3
3.21 b
3.29
3.29
T4
3.29 b
3.26
3.26
T5
3.18 b
3.29
3.29
Intervention
T0
5.53 a
χ2 = 47.41
P < 0.001
4.24 a
χ2 = 20.60
P < 0.001
3.74
χ2 = 7.14
p = 0.210
T1
3.47 b
3.71 b
3.56
T2
3.12 b
3.41 b
3.56
T3
3.15 b
3.41 b
3.38
T4
2.94 b
3.12 b
3.38
T5
2.79 b
3.12 b
3.38
*: Different lowercase letters indicate significant differences within each group (according to the Wilcoxon Signed Rank Test)

Sensitivity comparison among groups at different time points

When comparing groups using Mann-Whitney analysis, no significant difference was observed. But a different long-term trend was observed regarding only cold sensitivity. To be more specific, in terms of cold sensitivity, the intervention group experienced a decreasing trend till the last follow-up. But recurrent sensitivity was observed in the control group in long-term (Table 4).
Table 4
Cold sensitivity comparison among groups at different time points
Time
Group
No sensitivity
N (%) *
Mild sensitivity
Moderate Sensitivity
Severe sensitivity
Total
Mann-Whitney Test
T0
Control
0 (0)
2 (10.5)
14 (73.7)
3 (15.8)
(100)19
Z = 0.527
P = 0.598
Intervention
0 (0)
5 (26.3)
10 (52.6)
4 (21.1)
(100)19
T1
Control
5 (26.3)
8 (42.1)
6 (31.6)
0 (0)
(100)19
Z = 0.411
P = 0.681
Intervention
3 (15.8)
10 (52.6)
6 (31.6)
0 (0)
(100)19
T2
Control
5 (27.8)
6 (33.3)
7 (38.9)
0 (0)
(100)18
Z = 0.438
P = 0.662
Intervention
5 (27.8)
8 (44.4)
5 (27.8)
0 (0)
(100)18
T3
Control
4 (23.5)
6 (35.3)
7 (41.2)
0 (0)
(100)17
Z = 0.660
P = 0.509
Intervention
5 (29.4)
7 (41.2)
5 (29.4)
0 (0)
(100)17
T4
Control
2 (11.8)
9 (52.9)
6 (35.3)
0 (0)
(100)17
Z = 1.183
P = 0.237
Intervention
5 (29.4)
8 (47.1)
4 (23.5)
0 (0)
(100)17
T5
Control
3 (17.6)
8 (47.1)
6 (35.3)
0 (0)
(100)17
Z = 1.925
P = 0.054
Intervention
6 (35.3)
7 (41.2)
4 (23.5)
0 (0)
(100)17
*Number and percentage of subjects
In terms of changes in cold sensitivity over time, unlike the control group, where sensitivity recurred over time, the trend of sensitivity in the intervention group was downward until the third month, and a decrease in sensitivity was maintained in patients.

Discussion

The in-vitro and clinical investigation of the anti-sensitivity paste effectiveness containing L-arginine/calcium carbonate 8% and potassium nitrate demonstrated that the paste decreases the permeability, closes the dentinal tubules, and significantly reduces dentinal hypersensitivity (DH) regarding cold and tactile sensitivity in long term (3 months after treatment); therefore, the first null hypothesis was rejected. DH is linked to dentinal tubule permeability, resulting from factors like occlusal wear, deep caries, brushing abrasion, erosion, and parafunctional habits. Commonly, anti-sensitive toothpastes are used to alleviate DH and reduce patient discomfort [34].
According to the in-vitro results of this study, the initial average permeability of the study groups did not display significant differences. However, a noteworthy reduction in dentin permeability was observed in the intervention group after one week of paste use, indicating the effectiveness of the formulated paste in closing dentinal tubules. Consequently, the second null hypothesis of the research is rejected. These findings were further supported by microscopic examination (at X5000 magnification), which revealed predominantly open dentinal tubules in the control group, whereas the intervention group exhibited almost complete closure of the tubules, thereby reinforcing the study’s results.
This finding aligns with Parmar et al.’s study [18]. Their electron microscope analysis showed more closed tubules in the arginine group than in the control. Midha et al. [35] found positive effects for all anti-sensitive agents, with NovaMin, followed by arginine and potassium nitrate, most effective in closing dentine tubules. In contrast to Midha et al., Rajguru et al. [36] reported arginine paste as more efficient in closing tubules but found NovaMin to resist acid challenges better. Since the decrease in the permeability of dentinal tubules in laboratory conditions may be different from the changes that occur in the biological, complex, and dynamic environment of the mouth; further investigations under clinical conditions are necessary, that’s why this project was continued with a clinical investigation (phase 2).
Hydraulic conductivity refers to liquid transfer across a surface unit under pressure over time. Lab studies identify factors influencing dentin permeability, with various methods proposed for measurement [3740]. Dentin disc-based tubule closure assessment is the gold standard for hypersensitivity [41, 42]. In this study, SEM analysis followed dentine permeability assessment, and clinical evaluation included touch, cold, and spontaneous sensitivity.
According to the hydrodynamic theory, there are two primary approaches to treating DH: (1) closing dentinal tubules to minimize fluid flow in response to stimulation, and (2) reducing excitability in interdental nerves to minimize their response to fluid movements [43, 44]. Various commercial products are available for each mechanism, containing either single or multiple active substances, targeting only one anti-sensitive mechanism or employing a combination of methods (physical blockage and nerve stimulation).
In this study, the intervention group used a paste containing 8% L-arginine/calcium carbonate and potassium nitrate, while the control group used a base paste without the active anti-sensitive substance. Arginine, with an alkaline pH, has been proven effective in combination with calcium carbonate [13, 14]. It binds strongly to negatively charged dentin surfaces due to its cationic nature, forming rapid hydrogen bonds and create a calcium-rich layer [13, 14, 45]. The arginine-calcium carbonate method involves natural processes that block dentinal tubules with calcium-rich materials [11]. In contrast, the potassium nitrate approach elevates potassium concentration in nerve terminals, preventing action potentials in interdental nerves and pain message transmission by causing depolarization and inhibiting repolarization. Potassium nitrate (5%), potassium chloride (3.75%), and potassium citrate (5.5%), all of which contain 2% potassium ions, are used as active ingredients [25].
According to the clinical results of the present study, the study found that both groups experienced immediate cold sensitivity reduction after treatment, more pronounced in the intervention group, which also showed sustained long-term anti-sensitive effects compared to the base paste, over time. Unlike the control group, where sensitivity recurred over time, the sensitivity trend in the intervention group was downward steadily, maintaining lower levels until the third month. In terms of touch sensitivity, the intervention group consistently showed significant reductions over time, maintaining lower levels than before treatment. The same figure in the control group witnessed insignificant changes over-time, except immediately after the treatment. The two control and intervention groups showed no significant difference at each time point. For examining spontaneous sensitivity, there was no significant difference between the two groups at any time. In the intra-group comparison over time, as well as in the two-by-two before-after comparison, the level of spontaneous sensitivity did not show any significant changes.
Considering the noteworthy reduction in cold and touch sensitivity observed in the intervention group, this study aligns with previous research demonstrating the effectiveness of Pro-Argin-based pastes, both immediately after treatment and in subsequent evaluations at 3 days [46] or 2 weeks later [19, 47]. Hall et al. [48] examined the long-term effects of NovaMin and Pro-Argin pastes over 11 weeks, revealing significant sustained sensitivity reduction in agreement with the present findings. Investigations into the impact of potassium on sensitivity reduction, both individually [24] and in combinatio with fluoride ions [22], consistently corroborate each other and the current study, confirming the positive influence of potassium ions. In a study, Tolentino et al. [23] explored the effects of potassium nitrate and low-power laser, separately and concurrently, on dentin sensitivity reduction. They found that the combined treatment of these mechanisms proved more effective than individual approaches, suggesting a multi-session protocol with a minimum of three consecutive sessions to maintain prolonged desensitization. Mahesuti et al. [49] compared UltraEZ, a 5% potassium nitrate-based paste, to MI Paste containing CPP-ACP. They concluded that while potassium nitrate offered short-term and rapid effects, MI Paste provided slower but longer-lasting effects through tubular blocking. Although few studies have addressed spontaneous sensitivity, likely due to its measurement method’s unreliability in evaluation sessions, there remains an unexplored avenue for investigating the combined effect of arginine and potassium, despite the established efficacy of each substance independently.
The Air Blast test measured cold sensitivity, and probe movement assessed touch sensitivity. The Air Blast test is a common, controllable and repeatable method for this purpose [50]. The Visual Analog Scale (VAS) was utilized to recorded dental sensitivity at various times. VAS is an accurate scale for tooth sensitivity diagnosis based on previous studies [51, 52]. An issue with VAS is its reliance on individual pain tolerance. To solve this, the Split-Mouth method was employed, making each individual both the intervention and control group simultaneously, which consequently reduces the negative impact of confounding factors. Several studies have previously used and proven the reliability of the split-mouth method to assess tooth sensitivity [53, 54].
A clinical trial should have an appropriate duration to observe the maximum effect of the active substance while minimizing placebo effects and confounding factors. In this study, we measured sensitivities at six time points: before treatment (T0), immediately after treatment (T1), 24 h (T2), one week (T3), one month (T4), and three months after treatment (T5). This three-month follow-up aligns with recent studies, such as Bae et al.’s review [50], where the long-term effects of anti-sensitive paste were evaluated over periods of four to twelve weeks.
Based on Wilcoxon test results showing significant sensitivity improvement over time, it’s evident that a single use of anti-sensitive substances reduces patient discomfort, and continued home use maintains treatment benefits. While previous studies recommend three days’ home use after in-office treatment [55], some studies extend this period to two weeks for optimal results [19, 22, 56, 57]. However, this extended home use presents challenges due to uncontrollable factors and variations in brushing methods. In this study, with participant consent for additional visits, in-office treatment was conducted in two 30-minute sessions on consecutive days.
In the current study, as many previous studies [19, 24, 56, 58], the reduction in sensitivity in the control group was also significant, with the intervention group showing a more significant and sustained decrease over time. Reduced sensitivity in control groups is common, influenced by factors like placebo effects [59, 60], participant awareness of the study [61], and the Hawthorne effect [56], where improved oral hygiene during the study period may contribute. The base paste’s components, such as silica, may contribute to dentin surface layer formation and permeability reduction [22]. Despite these effects, the base paste formulation retained silica for its benefits, including thickening and sensitivity reduction, aligning with intended market release.
In previous literature, physical blockage of tubules has proven more effective than reducing nerve excitability [35, 56, 62]. Studies show mixed results for desensitizers with potassium ions, with some expressing doubt [63] and others confirming their effectiveness [49, 6469]. No clear superiority has been established between these methods, suggesting that combining both approaches may yield better outcomes. Although dentinal tubule closure is a common approach in anti-sensitive toothpaste, no product permanently achieves this. Potassium ions also require prolonged use (2 weeks, up to 8 weeks for significant relief) [70], and there is debate about their effectiveness because they have to move inward to reach the pulpal nerves against the direction of the flow of dentin fluid to reach their point of action [71]. Thus, neither method alone is ideal.
The ideal goal for reducing sensitivity involve immediate pain relief while maintaining long-term effects. Most studies focus on the short-term impact of substances using the physical blockade desensitization method. For instance, clinical trials demonstrated that an 8% arginine and calcium carbonate combination (Pro-Argin Technology) provided “immediate” relief after just one application [72]. Another study by Minkoff et al. [73] examined strontium chloride’s desensitization effects, which were noticeable immediately and lasted for two more weeks. Conversely, the potassium ion mechanism often targets long-term relief. Bartold et al.’s study on potassium nitrate noted its cumulative effects taking weeks for a significant reduction in sensitivity [74]. The paste in this study achieved both goals, reducing short-term sensitivity (immediately and 24 h post-treatment) and maintaining effects in the long term (the downward trend until the final three-month evaluation), aligning with prior research on this topic.
This study combined two desensitizing methods using two substances to make it more effective. Although, chemically, no adverse reaction occurs between these two substances, but the immediate sealing of arginine/calcium carbonate may disturb the penetration of potassium ions and this possible interference must be considered. Limited research has simultaneously combined desensitizers to address dentin sensitivity. For example, Sowinski et al. [22] used a two-chamber syringe to administer potassium nitrate with stannous fluoride, ensuring separate paths with different pHs mixed only during application to avoid chemical interference. Parmar et al. [18] showed that initial sensitivity reduction with Pro-Argin paste is related to fully closed tubules, while semi-open or open tubules gradually close with repeated paste use, facilitating potassium ion penetration to reduce sensitivity. Our electron microscope images, aligned with prior research, revealed not all tubules closed with the Pro-Argin mechanism, leaving some open for potassium ion penetration. Sowinski et al. [22] indicated that these methods not only avoid interference but also enhance potassium’s effect, creating a layer that reduces fluid stimulation in tubules and allowing faster potassium ion travel to nerve terminals, especially in response to stimuli like cold, drying, and hyperosmotic solutions, causing tubular fluid outflow [75]. Another recent study also assessed the efficacy of a biomimetic nano-hydroxyapatite remineralizing solution on a hypomineralized enamel surface and its effect on enamel microhardness. The application of nano-hydroxyapatite solution induced a significant in-vitro decline of demineralized areas after the first week of application. Conversely, no significant differences were seen between untreated enamel surfaces and remineralized surfaces after 2 months of remineralizing treatment. Remineralized enamel showed significantly higher microhardness figures than demineralized enamel, but lower figures than intact enamel [76].

Limitations and future suggestions

The study had limitations due to a small number of patients and a limited treatment schedule. Economic and time constraints hindered conducting multi-session treatments, and the Fluid Filtration device lacked full standardization for research purposes, affecting the results. To standardize in-vitro specimens after abrasive papers use on the buccal height of contour, we had to assess the mid-buccal dentine. On the other hand, cervical dentine was assessed in clinical phase because most of the samples had tooth sensitivity due to gingival recession.
Future studies should investigate the efficacy of low-power laser therapy as a complementary approach to manage dentinal hypersensitivity, especially in cases of severe sensitivity. Additionally, thorough evaluations of sensitivity-reducing agents are advised to ensure their effectiveness in resisting acidic conditions. To enhance the credibility of sensitivity research, innovative study designs should be adopted to minimize the impact of the placebo effect.

Conclusion

The experimental paste containing 8% L-Arginine and CaCO3 plus KNO3 successfully decreased the dentinal permeability in-vitro. In addition, in the clinical phase of the study, the paste was successful at reducing tooth sensitivity either immediately (short-term) or in long-term. This shows its potential as a proactive action to prevent or treat tooth sensitivity. As such, it can be recommended for using in-office by the operator or at-home by patients in order to maintain and enhance the beneficial effects.

Acknowledgements

Not applicable.

Declarations

The protocol of this descriptive cross-sectional study was approved by the Research and Ethics Committee of Mashhad University of Medical Sciences (IR.MUMS.DENTISTRY.REC.1401.002). Written informed consent was sought from the participants prior to enrollment and is available upon any request to the corresponding author email.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Paramesh Y, Durgabhavani G, Suneelkumar C, Gonapa P, Rathod RT. Comparative clinical evaluation of two different formulated in-office newer desensitizing agents (Clinpro XT and Tokuyama Shield Force Plus) in reducing dentin hypersensitivity – A randomized clinical trial. J Conservative Dentistry Endodontics. 2023;26(6):682–7.CrossRef Paramesh Y, Durgabhavani G, Suneelkumar C, Gonapa P, Rathod RT. Comparative clinical evaluation of two different formulated in-office newer desensitizing agents (Clinpro XT and Tokuyama Shield Force Plus) in reducing dentin hypersensitivity – A randomized clinical trial. J Conservative Dentistry Endodontics. 2023;26(6):682–7.CrossRef
2.
Zurück zum Zitat Ide M, Wilson R, Ashley F. The reproducibility of methods of assessment for cervical dentine hypersensitivity. J Clin Periodontol. 2001;28(1):16–22.PubMedCrossRef Ide M, Wilson R, Ashley F. The reproducibility of methods of assessment for cervical dentine hypersensitivity. J Clin Periodontol. 2001;28(1):16–22.PubMedCrossRef
3.
Zurück zum Zitat Summitt JB, Robbins JW, Hilton TJ, Schwartz RS, Dos Santos J Jr. Fundamentals of operative dentistry: a contemporary approach. Quintessence Pub. Chicago; 2006. Summitt JB, Robbins JW, Hilton TJ, Schwartz RS, Dos Santos J Jr. Fundamentals of operative dentistry: a contemporary approach. Quintessence Pub. Chicago; 2006.
4.
Zurück zum Zitat Brännström M. Sensory mechanism in dentine editor. A hydrodynamic mechanism in the transmission of pain producing stimuli through the dentine. Pergammon Press Oxford; 1963. pp. 73–9. Brännström M. Sensory mechanism in dentine editor. A hydrodynamic mechanism in the transmission of pain producing stimuli through the dentine. Pergammon Press Oxford; 1963. pp. 73–9.
5.
Zurück zum Zitat Anderson CJ, Kugel G, Zou Y, Ferrari M, Gerlach R. A randomized, controlled, two-month pilot trial of stannous fluoride dentifrice versus sodium fluoride dentifrice after oxalate treatment for dentinal hypersensitivity. Clin Oral Invest. 2020;24(11):4043–9.CrossRef Anderson CJ, Kugel G, Zou Y, Ferrari M, Gerlach R. A randomized, controlled, two-month pilot trial of stannous fluoride dentifrice versus sodium fluoride dentifrice after oxalate treatment for dentinal hypersensitivity. Clin Oral Invest. 2020;24(11):4043–9.CrossRef
6.
Zurück zum Zitat Absi EG, Addy M, Adams D, Dentine. hypersensitivity. The development and evaluation of a replica technique to study sensitive and non-sensitive cervical dentine. J Clin Periodontol. 1989;16(3):190-5. Absi EG, Addy M, Adams D, Dentine. hypersensitivity. The development and evaluation of a replica technique to study sensitive and non-sensitive cervical dentine. J Clin Periodontol. 1989;16(3):190-5.
7.
Zurück zum Zitat Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R. Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin Periodontol. 1997;24(11):808–13.PubMedCrossRef Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R. Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin Periodontol. 1997;24(11):808–13.PubMedCrossRef
8.
Zurück zum Zitat Reynolds E. Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions. J Dent Res. 1997;76(9):1587–95.PubMedCrossRef Reynolds E. Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions. J Dent Res. 1997;76(9):1587–95.PubMedCrossRef
9.
Zurück zum Zitat Balakrishnan A, Jonathan R, Benin P, Kuumar A. Evaluation to determine the caries remineralization potential of three dentifrices: an in vitro study. J Conservative Dentistry. 2013;16(4):375.CrossRef Balakrishnan A, Jonathan R, Benin P, Kuumar A. Evaluation to determine the caries remineralization potential of three dentifrices: an in vitro study. J Conservative Dentistry. 2013;16(4):375.CrossRef
10.
Zurück zum Zitat Benjamin S, Roshni PS, Nainan MT. Seal that heals. World J Dentistry. 2012;3(3):243–6.CrossRef Benjamin S, Roshni PS, Nainan MT. Seal that heals. World J Dentistry. 2012;3(3):243–6.CrossRef
11.
Zurück zum Zitat Cummins D. Recent advances in dentin hypersensitivity: clinically proven treatments for instant and lasting sensitivity relief. Am J Dent. 2010;23:a3–13. Spec No A:. Cummins D. Recent advances in dentin hypersensitivity: clinically proven treatments for instant and lasting sensitivity relief. Am J Dent. 2010;23:a3–13. Spec No A:.
12.
Zurück zum Zitat Jena A, Kala S, Shashirekha G. Comparing the effectiveness of four desensitizing toothpastes on dentinal tubule occlusion: a scanning electron microscope analysis. J Conservative Dentistry Endodontics. 2017;20(4):269–72.CrossRef Jena A, Kala S, Shashirekha G. Comparing the effectiveness of four desensitizing toothpastes on dentinal tubule occlusion: a scanning electron microscope analysis. J Conservative Dentistry Endodontics. 2017;20(4):269–72.CrossRef
13.
Zurück zum Zitat Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988;153(3):1251–6.PubMedCrossRef Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 1988;153(3):1251–6.PubMedCrossRef
14.
Zurück zum Zitat Petrou I, Heu R, Stranick M, Lavender S, Zaidel L, Cummins D, et al. A breakthrough therapy for dentin hypersensitivity: how dental products containing 8% arginine and calcium carbonate work to deliver effective relief of sensitive teeth. J Clin Dent. 2009;20(1):23–31.PubMed Petrou I, Heu R, Stranick M, Lavender S, Zaidel L, Cummins D, et al. A breakthrough therapy for dentin hypersensitivity: how dental products containing 8% arginine and calcium carbonate work to deliver effective relief of sensitive teeth. J Clin Dent. 2009;20(1):23–31.PubMed
15.
Zurück zum Zitat Arantes DC, Limeira FIR, Yamauti M, Moreira AN, Abreu LG, Magalhães CS. Comparison of clinical efficacy of Pro-argin and NovaMin toothpastes in relieving dentin hypersensitivity: a systematic review and Meta-analysis. Oral Health Prev Dent. 2019;17(5):403–12.PubMed Arantes DC, Limeira FIR, Yamauti M, Moreira AN, Abreu LG, Magalhães CS. Comparison of clinical efficacy of Pro-argin and NovaMin toothpastes in relieving dentin hypersensitivity: a systematic review and Meta-analysis. Oral Health Prev Dent. 2019;17(5):403–12.PubMed
16.
Zurück zum Zitat Docimo R, Perugia C, Bartolino M, Maturo P, Montesani L, Zhang YP, et al. Comparative evaluation of the efficacy of three commercially available toothpastes on dentin hypersensitivity reduction: an eight-week clinical study. J Clin Dent. 2011;22(4):121–7.PubMed Docimo R, Perugia C, Bartolino M, Maturo P, Montesani L, Zhang YP, et al. Comparative evaluation of the efficacy of three commercially available toothpastes on dentin hypersensitivity reduction: an eight-week clinical study. J Clin Dent. 2011;22(4):121–7.PubMed
17.
Zurück zum Zitat Yan B, Yi J, Li Y, Chen Y, Shi Z. Arginine-containing toothpastes for dentin hypersensitivity: systematic review and meta-analysis. Quintessence Int. 2013;44(9):709–23.PubMed Yan B, Yi J, Li Y, Chen Y, Shi Z. Arginine-containing toothpastes for dentin hypersensitivity: systematic review and meta-analysis. Quintessence Int. 2013;44(9):709–23.PubMed
18.
Zurück zum Zitat Parmar M, Joshi S, Thakkar M, Joshi C, Rupakar P, Desai H. Comparative evaluation of Strontium Chloride Desensitizer and Novel Proarginin Desensitizer on Dentinal Tubule Occlusion-A scanning Electron microscopic study. Natl J Integr Res Med. 2018;7(6):85–92. Parmar M, Joshi S, Thakkar M, Joshi C, Rupakar P, Desai H. Comparative evaluation of Strontium Chloride Desensitizer and Novel Proarginin Desensitizer on Dentinal Tubule Occlusion-A scanning Electron microscopic study. Natl J Integr Res Med. 2018;7(6):85–92.
19.
Zurück zum Zitat Ongphichetmetha N, Lertpimonchai A, Champaiboon C. Bioactive glass and arginine dentifrices immediately relieved dentine hypersensitivity following non-surgical periodontal therapy: a randomized controlled trial. J Periodontol. 2022;93(2):246–55.PubMedCrossRef Ongphichetmetha N, Lertpimonchai A, Champaiboon C. Bioactive glass and arginine dentifrices immediately relieved dentine hypersensitivity following non-surgical periodontal therapy: a randomized controlled trial. J Periodontol. 2022;93(2):246–55.PubMedCrossRef
20.
Zurück zum Zitat Salian S, Thakur S, Kulkarni S, LaTorre G. A randomized controlled clinical study evaluating the efficacy of two desensitizing dentifrices. J Clin Dent. 2010;21(3):82–7.PubMed Salian S, Thakur S, Kulkarni S, LaTorre G. A randomized controlled clinical study evaluating the efficacy of two desensitizing dentifrices. J Clin Dent. 2010;21(3):82–7.PubMed
21.
Zurück zum Zitat Schiff T, Dotson M, Cohen S, De Vizio W, McCool J, Volpe A. Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: a twelve-week clinical study. J Clin Dent. 1994;5(Spec No):87–92.PubMed Schiff T, Dotson M, Cohen S, De Vizio W, McCool J, Volpe A. Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: a twelve-week clinical study. J Clin Dent. 1994;5(Spec No):87–92.PubMed
22.
Zurück zum Zitat Sowinski J, Ayad F, Petrone M, DeVizio W, Volpe A, Ellwood R, Davies R. Comparative investigations of the desensitising efficacy of a new dentifrice. J Clin Periodontol. 2001;28(11):1032–6.PubMedCrossRef Sowinski J, Ayad F, Petrone M, DeVizio W, Volpe A, Ellwood R, Davies R. Comparative investigations of the desensitising efficacy of a new dentifrice. J Clin Periodontol. 2001;28(11):1032–6.PubMedCrossRef
23.
Zurück zum Zitat Tolentino AB, Zeola LF, Fernandes MRU, Pannuti CM, Soares PV, Aranha ACC. Photobiomodulation therapy and 3% potassium nitrate gel as treatment of cervical dentin hypersensitivity: a randomized clinical trial. Clin Oral Investig. 2022:1–9. Tolentino AB, Zeola LF, Fernandes MRU, Pannuti CM, Soares PV, Aranha ACC. Photobiomodulation therapy and 3% potassium nitrate gel as treatment of cervical dentin hypersensitivity: a randomized clinical trial. Clin Oral Investig. 2022:1–9.
24.
Zurück zum Zitat Nagata T, Ishida H, Shinohara H, Nishikawa S, Kasahara S, Wakano Y, et al. Clinical evaluation of a potassium nitrate dentifrice for the treatment of dentinal hypersensitivity. J Clin Periodontol. 1994;21(3):217–21.PubMedCrossRef Nagata T, Ishida H, Shinohara H, Nishikawa S, Kasahara S, Wakano Y, et al. Clinical evaluation of a potassium nitrate dentifrice for the treatment of dentinal hypersensitivity. J Clin Periodontol. 1994;21(3):217–21.PubMedCrossRef
25.
Zurück zum Zitat Davies R, Scully C, Preston AJ. Dentifrices–an update. Med oral Patologia oral y Cir Bucal. 2010;15(6):e976–82.CrossRef Davies R, Scully C, Preston AJ. Dentifrices–an update. Med oral Patologia oral y Cir Bucal. 2010;15(6):e976–82.CrossRef
26.
Zurück zum Zitat Barros APO, de Melo Alencar C, de Melo Pingarilho Carneiro A, da Silva Pompeu D, Barbosa GM, Araújo JLN, Silva CM. Combination of two desensitizing protocols to control dentin hypersensitivity in non-carious lesions: a randomized, double-blind clinical trial. Clin Oral Investig. 2022;26(2):1299–307.PubMedCrossRef Barros APO, de Melo Alencar C, de Melo Pingarilho Carneiro A, da Silva Pompeu D, Barbosa GM, Araújo JLN, Silva CM. Combination of two desensitizing protocols to control dentin hypersensitivity in non-carious lesions: a randomized, double-blind clinical trial. Clin Oral Investig. 2022;26(2):1299–307.PubMedCrossRef
27.
Zurück zum Zitat Idon PI, Sotunde OA, Ogundare TO. Beyond the relief of Pain: dentin hypersensitivity and oral health-related quality of life. Front Dent. 2019;16(5):325–34.PubMedPubMedCentral Idon PI, Sotunde OA, Ogundare TO. Beyond the relief of Pain: dentin hypersensitivity and oral health-related quality of life. Front Dent. 2019;16(5):325–34.PubMedPubMedCentral
28.
Zurück zum Zitat Orchardson R, Gillam DG. Managing dentin hypersensitivity. J Am Dent Association. 2006;137(7):990–8.CrossRef Orchardson R, Gillam DG. Managing dentin hypersensitivity. J Am Dent Association. 2006;137(7):990–8.CrossRef
29.
Zurück zum Zitat Pandis N, Chung B, Scherer RW, Elbourne D, Altman DG. CONSORT 2010 statement: extension checklist for reporting within person randomised trials. Br J Dermatol. 2019;180(3):534–52.PubMedCrossRef Pandis N, Chung B, Scherer RW, Elbourne D, Altman DG. CONSORT 2010 statement: extension checklist for reporting within person randomised trials. Br J Dermatol. 2019;180(3):534–52.PubMedCrossRef
30.
Zurück zum Zitat McKnight-Hanes C, Whitford GM. Fluoride release from three glass ionomer materials and the effects of varnishing with or without finishing. Caries Res. 1992;26(5):345–50.PubMedCrossRef McKnight-Hanes C, Whitford GM. Fluoride release from three glass ionomer materials and the effects of varnishing with or without finishing. Caries Res. 1992;26(5):345–50.PubMedCrossRef
31.
Zurück zum Zitat Zhou J, Chiba A, Scheffel DL, Hebling J, Agee K, Niu L-n, et al. Effects of a dicalcium and tetracalcium phosphate-based desensitizer on in vitro dentin permeability. PLoS ONE. 2016;11(6):e0158400.PubMedPubMedCentralCrossRef Zhou J, Chiba A, Scheffel DL, Hebling J, Agee K, Niu L-n, et al. Effects of a dicalcium and tetracalcium phosphate-based desensitizer on in vitro dentin permeability. PLoS ONE. 2016;11(6):e0158400.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Boruziniat A, Khosravi F, Shahri A, Saeedi M. Effect of preheating nano-hybrid and bulk-fill composites with warm airstream on their microtensile bond strength to dentin. J Conservative Dentistry Endodontics. 2023;26(6):702–8.CrossRef Boruziniat A, Khosravi F, Shahri A, Saeedi M. Effect of preheating nano-hybrid and bulk-fill composites with warm airstream on their microtensile bond strength to dentin. J Conservative Dentistry Endodontics. 2023;26(6):702–8.CrossRef
33.
Zurück zum Zitat Soares R, De Ataide IDN, Fernandes M, Lambor R. Assessment of enamel remineralisation after treatment with four different remineralising agents: a scanning electron microscopy (SEM) study. J Clin Diagn Res. 2017;11(4):ZC136.PubMedPubMedCentral Soares R, De Ataide IDN, Fernandes M, Lambor R. Assessment of enamel remineralisation after treatment with four different remineralising agents: a scanning electron microscopy (SEM) study. J Clin Diagn Res. 2017;11(4):ZC136.PubMedPubMedCentral
34.
Zurück zum Zitat Mathew MG, Soni AJ, Khan MM, Kauser A, Charan VSS, Akula SK. Efficacy of remineralizing agents to occlude dentinal tubules in primary teeth subjected to dentin hypersensitivity in vitro: SEM study. J Family Med Prim care. 2020;9(1):354–8.PubMedPubMedCentralCrossRef Mathew MG, Soni AJ, Khan MM, Kauser A, Charan VSS, Akula SK. Efficacy of remineralizing agents to occlude dentinal tubules in primary teeth subjected to dentin hypersensitivity in vitro: SEM study. J Family Med Prim care. 2020;9(1):354–8.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Midha V, Midha V, Kochhar AS, Kochhar GK, Bhasin R, Dadlani H. Evaluating the efficacy of desensitizing dentifrices on dentinal hypersensitivity management: a scanning electron microscopic analysis. J Indian Soc Periodontology. 2021;25(4):283–7.CrossRef Midha V, Midha V, Kochhar AS, Kochhar GK, Bhasin R, Dadlani H. Evaluating the efficacy of desensitizing dentifrices on dentinal hypersensitivity management: a scanning electron microscopic analysis. J Indian Soc Periodontology. 2021;25(4):283–7.CrossRef
36.
Zurück zum Zitat Rajguru S, Padhye A, Gupta H. Effects of two desensitizing dentifrices on dentinal tubule occlusion with citric acid challenge: confocal laser scanning microscopy study. Indian J Dent Res. 2017;28(4):450–6.PubMedCrossRef Rajguru S, Padhye A, Gupta H. Effects of two desensitizing dentifrices on dentinal tubule occlusion with citric acid challenge: confocal laser scanning microscopy study. Indian J Dent Res. 2017;28(4):450–6.PubMedCrossRef
37.
Zurück zum Zitat Outhwaite WC, McKenzie DM, Pashley DH. A versatile split-chamber device for studying dentin permeability. J Dent Res. 1974;53(6):1503.PubMedCrossRef Outhwaite WC, McKenzie DM, Pashley DH. A versatile split-chamber device for studying dentin permeability. J Dent Res. 1974;53(6):1503.PubMedCrossRef
38.
Zurück zum Zitat Pashley DH, Livingston MJ, Greenhill JD. Regional resistances to fluid flow in human dentine in vitro. Arch Oral Biol. 1978;23(9):807–10.PubMedCrossRef Pashley DH, Livingston MJ, Greenhill JD. Regional resistances to fluid flow in human dentine in vitro. Arch Oral Biol. 1978;23(9):807–10.PubMedCrossRef
39.
Zurück zum Zitat Ghazali FB. Permeability of dentine. Malaysian J Med Sciences: MJMS. 2003;10(1):27–36. Ghazali FB. Permeability of dentine. Malaysian J Med Sciences: MJMS. 2003;10(1):27–36.
40.
Zurück zum Zitat von Fraunhofer JA, Hammer DW. Microleakage of composite resin restorations. J Prosthet Dent. 1984;51(2):209–13.CrossRef von Fraunhofer JA, Hammer DW. Microleakage of composite resin restorations. J Prosthet Dent. 1984;51(2):209–13.CrossRef
41.
Zurück zum Zitat Kolker JL, Vargas MA, Armstrong SR, Dawson DV. Effect of desensitizing agents on dentin permeability and dentin tubule occlusion. J Adhesive Dentistry. 2002;4:211–22. Kolker JL, Vargas MA, Armstrong SR, Dawson DV. Effect of desensitizing agents on dentin permeability and dentin tubule occlusion. J Adhesive Dentistry. 2002;4:211–22.
42.
Zurück zum Zitat Gillam D, Mordan N, Sinodinou A, Tang J, Knowles J, Gibson IR. The effects of oxalate-containing products on the exposed dentine surface: an SEM investigation. J Rehabil. 2001;28(11):1037–44. Gillam D, Mordan N, Sinodinou A, Tang J, Knowles J, Gibson IR. The effects of oxalate-containing products on the exposed dentine surface: an SEM investigation. J Rehabil. 2001;28(11):1037–44.
43.
Zurück zum Zitat Orchardson R, Gillam DG. The efficacy of potassium salts as agents for treating dentin hypersensitivity. J Orofac Pain. 2000;14(1). Orchardson R, Gillam DG. The efficacy of potassium salts as agents for treating dentin hypersensitivity. J Orofac Pain. 2000;14(1).
44.
Zurück zum Zitat Meng Y, Huang F, Wang S, Huang X, Lu Y, Li Y, et al. Evaluation of dentinal tubule occlusion and pulp tissue response after using 980-nm diode laser for dentin hypersensitivity treatment. Clin Oral Invest. 2023;27(8):4843–54.CrossRef Meng Y, Huang F, Wang S, Huang X, Lu Y, Li Y, et al. Evaluation of dentinal tubule occlusion and pulp tissue response after using 980-nm diode laser for dentin hypersensitivity treatment. Clin Oral Invest. 2023;27(8):4843–54.CrossRef
45.
Zurück zum Zitat Markowitz K. A new treatment alternative for sensitive teeth: a desensitizing oral rinse. J Dent. 2013;41(Suppl 1):S1–11.PubMedCrossRef Markowitz K. A new treatment alternative for sensitive teeth: a desensitizing oral rinse. J Dent. 2013;41(Suppl 1):S1–11.PubMedCrossRef
46.
Zurück zum Zitat Fu Y, Li X, Que K, Wang M, Hu D, Mateo LR et al. Instant dentin hypersensitivity relief of a new desensitizing dentifrice containing 8.0% arginine, a high cleaning calcium carbonate system and 1450 ppm fluoride: a 3-day clinical study in Chengdu, China. Am J Dent. 2010;23 Spec No A:20a-7a. Fu Y, Li X, Que K, Wang M, Hu D, Mateo LR et al. Instant dentin hypersensitivity relief of a new desensitizing dentifrice containing 8.0% arginine, a high cleaning calcium carbonate system and 1450 ppm fluoride: a 3-day clinical study in Chengdu, China. Am J Dent. 2010;23 Spec No A:20a-7a.
47.
Zurück zum Zitat Que K, Fu Y, Lin L, Hu D, Zhang YP, Panagakos FS et al. Dentin hypersensitivity reduction of a new toothpaste containing 8.0% arginine and 1450 ppm fluoride: an 8-week clinical study on Chinese adults. Am J Dent. 2010;23 Spec No A:a28–35. Que K, Fu Y, Lin L, Hu D, Zhang YP, Panagakos FS et al. Dentin hypersensitivity reduction of a new toothpaste containing 8.0% arginine and 1450 ppm fluoride: an 8-week clinical study on Chinese adults. Am J Dent. 2010;23 Spec No A:a28–35.
48.
Zurück zum Zitat Hall C, Mason S, Cooke J. Exploratory randomised controlled clinical study to evaluate the comparative efficacy of two occluding toothpastes - a 5% calcium sodium phosphosilicate toothpaste and an 8% arginine/calcium carbonate toothpaste - for the longer-term relief of dentine hypersensitivity. J Dent. 2017;60:36–43.PubMedCrossRef Hall C, Mason S, Cooke J. Exploratory randomised controlled clinical study to evaluate the comparative efficacy of two occluding toothpastes - a 5% calcium sodium phosphosilicate toothpaste and an 8% arginine/calcium carbonate toothpaste - for the longer-term relief of dentine hypersensitivity. J Dent. 2017;60:36–43.PubMedCrossRef
49.
Zurück zum Zitat Mahesuti A, Duan YL, Wang G, Cheng XR, Matis BA. Short-term efficacy of agents containing KNO3 or CPP-ACP in treatment of dentin hypersensitivity. Chin J Dent Res. 2014;17(1):43–7.PubMed Mahesuti A, Duan YL, Wang G, Cheng XR, Matis BA. Short-term efficacy of agents containing KNO3 or CPP-ACP in treatment of dentin hypersensitivity. Chin J Dent Res. 2014;17(1):43–7.PubMed
50.
Zurück zum Zitat Bae JH, Kim YK, Myung S-K. Desensitizing toothpaste versus placebo for dentin hypersensitivity: a systematic review and meta-analysis. J Clin Periodontol. 2014;42. Bae JH, Kim YK, Myung S-K. Desensitizing toothpaste versus placebo for dentin hypersensitivity: a systematic review and meta-analysis. J Clin Periodontol. 2014;42.
51.
Zurück zum Zitat Rocha MOC, Cruz AACF, Santos DO, Douglas-DE-Oliveira DW, Flecha OD, Gonçalves PF. Sensitivity and specificity of assessment scales of dentin hypersensitivity–an accuracy study. Brazilian oral Res. 2020;34:e043.CrossRef Rocha MOC, Cruz AACF, Santos DO, Douglas-DE-Oliveira DW, Flecha OD, Gonçalves PF. Sensitivity and specificity of assessment scales of dentin hypersensitivity–an accuracy study. Brazilian oral Res. 2020;34:e043.CrossRef
52.
Zurück zum Zitat Skovlund E, Breivik H. Analysis of pain-intensity measurements. Scand J Pain. 2016;13:123–4.PubMedCrossRef Skovlund E, Breivik H. Analysis of pain-intensity measurements. Scand J Pain. 2016;13:123–4.PubMedCrossRef
53.
Zurück zum Zitat Mohammadipour HS, Bagheri H, Akbari M, Behzadi S, Ramezanian N, Javanshir S, Khorshid M. The effect of sodium hexametaphosphate on sensitivity and whitening effectiveness of an at-home bleaching gel: a randomized, triple-blinded clinical trial. Quintessence Int. 2021;52(7):596–605.PubMed Mohammadipour HS, Bagheri H, Akbari M, Behzadi S, Ramezanian N, Javanshir S, Khorshid M. The effect of sodium hexametaphosphate on sensitivity and whitening effectiveness of an at-home bleaching gel: a randomized, triple-blinded clinical trial. Quintessence Int. 2021;52(7):596–605.PubMed
54.
Zurück zum Zitat Ravishankar P, Viswanath V, Archana D, Keerthi V, Dhanapal S, Priya KPL. The effect of three desensitizing agents on dentin hypersensitivity: a randomized, split-mouth clinical trial. Indian J Dent Res. 2018;29(1):51–5.PubMedCrossRef Ravishankar P, Viswanath V, Archana D, Keerthi V, Dhanapal S, Priya KPL. The effect of three desensitizing agents on dentin hypersensitivity: a randomized, split-mouth clinical trial. Indian J Dent Res. 2018;29(1):51–5.PubMedCrossRef
55.
Zurück zum Zitat Ayad F, Ayad N, Delgado E, Zhang YP, DeVizio W, Cummins D, Mateo LR. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in Mississauga, Canada. J Clin Dent. 2009;20(4):115–22.PubMed Ayad F, Ayad N, Delgado E, Zhang YP, DeVizio W, Cummins D, Mateo LR. Comparing the efficacy in providing instant relief of dentin hypersensitivity of a new toothpaste containing 8.0% arginine, calcium carbonate, and 1450 ppm fluoride to a benchmark desensitizing toothpaste containing 2% potassium ion and 1450 ppm fluoride, and to a control toothpaste with 1450 ppm fluoride: a three-day clinical study in Mississauga, Canada. J Clin Dent. 2009;20(4):115–22.PubMed
56.
Zurück zum Zitat Pradeep AR, Sharma A. Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: a randomized clinical trial. J Periodontol. 2010;81(8):1167–73.PubMedCrossRef Pradeep AR, Sharma A. Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: a randomized clinical trial. J Periodontol. 2010;81(8):1167–73.PubMedCrossRef
57.
Zurück zum Zitat Pradeep AR, Agarwal E, Naik SB, Bajaj P, Kalra N. Comparison of efficacy of three commercially available dentifrices [corrected] on dentinal hypersensitivity: a randomized clinical trial. Aust Dent J. 2012;57(4):429–34.PubMedCrossRef Pradeep AR, Agarwal E, Naik SB, Bajaj P, Kalra N. Comparison of efficacy of three commercially available dentifrices [corrected] on dentinal hypersensitivity: a randomized clinical trial. Aust Dent J. 2012;57(4):429–34.PubMedCrossRef
58.
Zurück zum Zitat West NX, Hughes JA, Addy M. Dentine hypersensitivity: the effects of brushing toothpaste on etched and unetched dentine in vitro. J Oral Rehabil. 2002;29(2):167–74.PubMedCrossRef West NX, Hughes JA, Addy M. Dentine hypersensitivity: the effects of brushing toothpaste on etched and unetched dentine in vitro. J Oral Rehabil. 2002;29(2):167–74.PubMedCrossRef
59.
Zurück zum Zitat Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM. Network meta-analysis on the effect of desensitizing toothpastes on dentine hypersensitivity. J Dent. 2019;88:103170.PubMedCrossRef Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM. Network meta-analysis on the effect of desensitizing toothpastes on dentine hypersensitivity. J Dent. 2019;88:103170.PubMedCrossRef
60.
Zurück zum Zitat Uchida A, Wakano Y, Fukuyama O, Miki T, Iwayama Y, Okada H. Controlled clinical evaluation of a 10% strontium chloride dentifrice in treatment of dentin hypersensitivity following periodontal surgery. J Periodontol. 1980;51(10):578–81.PubMedCrossRef Uchida A, Wakano Y, Fukuyama O, Miki T, Iwayama Y, Okada H. Controlled clinical evaluation of a 10% strontium chloride dentifrice in treatment of dentin hypersensitivity following periodontal surgery. J Periodontol. 1980;51(10):578–81.PubMedCrossRef
61.
Zurück zum Zitat Trowbridge HO, Silver DR. A review of current approaches to in-office management of tooth hypersensitivity. Dent Clin North Am. 1990;34(3):561–81.PubMedCrossRef Trowbridge HO, Silver DR. A review of current approaches to in-office management of tooth hypersensitivity. Dent Clin North Am. 1990;34(3):561–81.PubMedCrossRef
62.
Zurück zum Zitat Kakar A, Kakar K, Sreenivasan PK, DeVizio W, Kohli R. Comparison of the clinical efficacy of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm fluoride to a commercially available sensitive toothpaste containing 2% potassium ion on dentin hypersensitivity: a randomized clinical trial. J Clin Dent. 2012;23(2):40–7.PubMed Kakar A, Kakar K, Sreenivasan PK, DeVizio W, Kohli R. Comparison of the clinical efficacy of a new dentifrice containing 8.0% arginine, calcium carbonate, and 1000 ppm fluoride to a commercially available sensitive toothpaste containing 2% potassium ion on dentin hypersensitivity: a randomized clinical trial. J Clin Dent. 2012;23(2):40–7.PubMed
63.
Zurück zum Zitat Martini EC, Favoreto MW, Rezende M, de Geus JL, Loguercio AD, Reis A. Topical application of a desensitizing agent containing potassium nitrate before dental bleaching: a systematic review and meta-analysis. Clin Oral Investig. 2021;25(7):4311–27.PubMedCrossRef Martini EC, Favoreto MW, Rezende M, de Geus JL, Loguercio AD, Reis A. Topical application of a desensitizing agent containing potassium nitrate before dental bleaching: a systematic review and meta-analysis. Clin Oral Investig. 2021;25(7):4311–27.PubMedCrossRef
64.
Zurück zum Zitat Marto CM, Baptista Paula A, Nunes T, Pimenta M, Abrantes AM, Pires AS, et al. Evaluation of the efficacy of dentin hypersensitivity treatments-A systematic review and follow-up analysis. J Oral Rehabil. 2019;46(10):952–90.PubMedCrossRef Marto CM, Baptista Paula A, Nunes T, Pimenta M, Abrantes AM, Pires AS, et al. Evaluation of the efficacy of dentin hypersensitivity treatments-A systematic review and follow-up analysis. J Oral Rehabil. 2019;46(10):952–90.PubMedCrossRef
65.
Zurück zum Zitat Frechoso SC, Menéndez M, Guisasola C, Arregui I, Tejerina JM, Sicilia A. Evaluation of the efficacy of two potassium nitrate bioadhesive gels (5% and 10%) in the treatment of dentine hypersensitivity. A randomised clinical trial. J Clin Periodontol. 2003;30(4):315–20.PubMedCrossRef Frechoso SC, Menéndez M, Guisasola C, Arregui I, Tejerina JM, Sicilia A. Evaluation of the efficacy of two potassium nitrate bioadhesive gels (5% and 10%) in the treatment of dentine hypersensitivity. A randomised clinical trial. J Clin Periodontol. 2003;30(4):315–20.PubMedCrossRef
66.
Zurück zum Zitat Galvão AM, Zeola LF, Moura GF, Teixeira DNR, Gonzaga RCQ, da Silva GR, Soares PV. A long-term evaluation of experimental potassium oxalate concentrations on dentin hypersensitivity reduction: a triple-blind randomized clinical trial. J Dent. 2019;89:103180.PubMedCrossRef Galvão AM, Zeola LF, Moura GF, Teixeira DNR, Gonzaga RCQ, da Silva GR, Soares PV. A long-term evaluation of experimental potassium oxalate concentrations on dentin hypersensitivity reduction: a triple-blind randomized clinical trial. J Dent. 2019;89:103180.PubMedCrossRef
67.
Zurück zum Zitat Liu H, Hu D. Efficacy of a commercial dentifrice containing 2% strontium chloride and 5% potassium nitrate for dentin hypersensitivity: a 3-Day clinical study in adults in China. Clin Ther. 2012;34(3):614–22.PubMedCrossRef Liu H, Hu D. Efficacy of a commercial dentifrice containing 2% strontium chloride and 5% potassium nitrate for dentin hypersensitivity: a 3-Day clinical study in adults in China. Clin Ther. 2012;34(3):614–22.PubMedCrossRef
68.
Zurück zum Zitat Purra AR, Mushtaq M, Acharya SR, Saraswati V. A comparative evaluation of propolis and 5.0% potassium nitrate as a dentine desensitizer: a clinical study. J Indian Soc Periodontology. 2014;18(4):466–71.CrossRef Purra AR, Mushtaq M, Acharya SR, Saraswati V. A comparative evaluation of propolis and 5.0% potassium nitrate as a dentine desensitizer: a clinical study. J Indian Soc Periodontology. 2014;18(4):466–71.CrossRef
69.
Zurück zum Zitat Vieira AHM, Passos VF, de Assis JS, Mendonça JS, Santiago SL. Clinical evaluation of a 3% potassium oxalate gel and a GaAlAs laser for the treatment of Dentinal Hypersensitivity. Photomed Laser Surg. 2009;27(5):807–12.PubMedCrossRef Vieira AHM, Passos VF, de Assis JS, Mendonça JS, Santiago SL. Clinical evaluation of a 3% potassium oxalate gel and a GaAlAs laser for the treatment of Dentinal Hypersensitivity. Photomed Laser Surg. 2009;27(5):807–12.PubMedCrossRef
70.
Zurück zum Zitat Cummins D. Dentin hypersensitivity: from diagnosis to a breakthrough therapy for everyday sensitivity relief. J Clin Dent. 2009;20(1):1–9.PubMed Cummins D. Dentin hypersensitivity: from diagnosis to a breakthrough therapy for everyday sensitivity relief. J Clin Dent. 2009;20(1):1–9.PubMed
71.
Zurück zum Zitat Sena FJ. Dentinal permeability in assessing therapeutic agents. Dent Clin North Am. 1990;34(3):475–90.PubMedCrossRef Sena FJ. Dentinal permeability in assessing therapeutic agents. Dent Clin North Am. 1990;34(3):475–90.PubMedCrossRef
72.
Zurück zum Zitat Kerns DG, Scheidt MJ, Pashley DH, Horner JA, Strong SL, Van Dyke TE. Dentinal tubule occlusion and root hypersensitivity. J Periodontol. 1991;62(7):421–8.PubMedCrossRef Kerns DG, Scheidt MJ, Pashley DH, Horner JA, Strong SL, Van Dyke TE. Dentinal tubule occlusion and root hypersensitivity. J Periodontol. 1991;62(7):421–8.PubMedCrossRef
73.
Zurück zum Zitat Minkoff S, Axelrod S. Efficacy of strontium chloride in dental hypersensitivity. J Periodontol. 1987;58(7):470–4.PubMedCrossRef Minkoff S, Axelrod S. Efficacy of strontium chloride in dental hypersensitivity. J Periodontol. 1987;58(7):470–4.PubMedCrossRef
75.
Zurück zum Zitat Berman LH. Dentinal sensation and hypersensitivity. A review of mechanisms and treatment alternatives. J Periodontol. 1985;56(4):216–22.PubMedCrossRef Berman LH. Dentinal sensation and hypersensitivity. A review of mechanisms and treatment alternatives. J Periodontol. 1985;56(4):216–22.PubMedCrossRef
76.
Zurück zum Zitat Scribante A, Dermenaki Farahani MR, Marino G, Matera C, Rodriguez y Baena R, Lanteri V, Butera A. Biomimetic effect of nano-hydroxyapatite in demineralized enamel before orthodontic bonding of brackets and attachments: visual, adhesion strength, and hardness in in vitro tests. BioMed Research International. 2020;2020. Scribante A, Dermenaki Farahani MR, Marino G, Matera C, Rodriguez y Baena R, Lanteri V, Butera A. Biomimetic effect of nano-hydroxyapatite in demineralized enamel before orthodontic bonding of brackets and attachments: visual, adhesion strength, and hardness in in vitro tests. BioMed Research International. 2020;2020.
Metadaten
Titel
Evaluation and comparison of the effects of a new paste containing 8% L-Arginine and CaCO3 plus KNO3 on dentinal tubules occlusion and dental sensitivity: a randomized, triple blinded clinical trial study
verfasst von
Hamideh Sadat Mohammadipour
Hossein Bagheri
Saber Babazadeh
Mehrzad Khorshid
Zahra Shooshtari
Arsalan Shahri
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Oral Health / Ausgabe 1/2024
Elektronische ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-024-04298-3

Weitere Artikel der Ausgabe 1/2024

BMC Oral Health 1/2024 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.